The Future of AI In Medical Diagnosis: In Conversation With PathAI CEO Dr. Andy Beck
vitalsignshealth.substack.com
For our second crossover episode between Vital Signs and Unsupervised Learning we explored the impact of AI on pathology with PathAI Co-Founder and CEO Dr. Andy Beck. Andy talked about his journey studying both pathology and computer science throughout his MD and PhD programs, as well as how advances in computer vision created the opportunity to start PathAI (last valued at close to $1B). We also hit on why Path acquired their own lab and how larger foundation models have changed their products.
The Future of AI In Medical Diagnosis: In Conversation With PathAI CEO Dr. Andy Beck
The Future of AI In Medical Diagnosis: In…
The Future of AI In Medical Diagnosis: In Conversation With PathAI CEO Dr. Andy Beck
For our second crossover episode between Vital Signs and Unsupervised Learning we explored the impact of AI on pathology with PathAI Co-Founder and CEO Dr. Andy Beck. Andy talked about his journey studying both pathology and computer science throughout his MD and PhD programs, as well as how advances in computer vision created the opportunity to start PathAI (last valued at close to $1B). We also hit on why Path acquired their own lab and how larger foundation models have changed their products.